Medtronic Aims To Boost Ortho Presence In China With Weigao Joint Venture
This article was originally published in PharmAsia News
Executive Summary
Medtronic's joint venture with China-based device maker Shandong Weigao for marketing of spinal and other orthopedic products in China gives Medtronic a 15 percent stake in Weigao for $221 million
You may also be interested in...
Chinese Device Maker Weigao Banks On Medtronic’s Brand Name For International Backbone
SHANGHAI - A new joint venture formed with Medtronic will give Chinese device maker Weigao the international presence it needs to bring the international market to its orthopedic products
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).